“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A study looking at MRI scans to assess response to treatment for ovarian, peritoneal or fallopian tube cancer (DISCOVAR)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
More about this trial
The researchers think a new type of MRI scan called a diffusion weighted MRI scan may be better. They want to find out if this is so.
Who can enter
To enter this study, you must
- Have ovarian cancer (stage 3 or 4), peritoneal cancer or fallopian tube cancer that has spread to another part of the body
- Have a CT scan that shows at least 1 area of cancer that measures at least 2cm across
- Be at least 18 years old
There are 2 groups in this study. To be in group 1, you must also be
- Having chemotherapy with either carboplatin or cisplatin or having a combination of 2 chemotherapy drugs with one being a
platinum drugbefore having surgery
To be in group 2, you must
- Have had a CT scan that shows your cancer has come back after treatment
- Be having chemotherapy with either carboplatin or cisplatin or having a combination of 2 chemotherapy drugs with one being a platinum drug
You cannot enter this trial if you
- Have serous type ovarian cancer that is low grade
- Are not able to have an MRI scan, for example because you have a pacemaker or other metal in your body, or are not able to be in confined spaces
- Are not able to lie flat
- Have had radiotherapy to your tummy (abdomen) or area between your hips (pelvis) in the past 6 months
- Have a blocked bowel (bowel obstruction)
- Have fluid collected in your tummy (ascites) that prevents you having a MRI scan
- Have had an experimental drug or used an experimental device as part of another clinical trial in the past month
- Have any other medical condition that could affect you taking part in this study
This is an observational study. There are 2 groups in this study. In group 1 the study will recruit 40 women. In group 2 the study will recruit 80 women.
In group 1 you have 2 MRI scans before starting your course of chemotherapy. You have another MRI before your surgery.
In group 2 you have a MRI scan before starting your course of chemotherapy. You have 2 more MRI scans during your course of chemotherapy.
Before each MRI scan you have an injection of a drug called buscopan. This helps relax your bowels to give a clearer picture of your tummy (abdomen).
You have 3 extra visits to the hospital for the MRI scans. Each scan takes about 40 to 50 minutes.
You may have a dry mouth and blurred vision for about 30 minutes after having the buscopan.
How to join a clinical trial
Professor Nandita Desouza
Cancer Research UK
NIHR Clinical Research Network: Cancer